20_2_4

Continuing Education Series

Treatment of restless legs syndrome in patients with chronic kidney disease: A focus on medications

By Colette B. Raymond, PharmD, MSc, Lance Breland, BScPharm,Lori D.Wazny, PharmD,Amy R. Sood, PharmD, and Cali D. Orsulak, BScPharm

Objectives

After reading the article, the reader will be able to:

• Describe symptoms of restless legs syndrome (RLS)

• Describe the differences between intermittent, daily and refractory RLS

• Describe conditions and medications associated with RLS

• Describe non-pharmacologic measures that patients can employ to manage RLS symptoms

• Compare and contrast currently available pharmacologic agents to treat RLS symptoms.